5 Pharmaceutical preparations for the treatment of hyponatremia, in patients with Syndrome of Inappropriate Antidiuretic Hormone (SIADH), heart failure and cirrhosis
Color is not claimed as a feature of the mark. "(TOLVAPTAN)" The mark consists of "SAMSCA" in a stylized font centered over an image of a liquid droplet. The term "TOLVAPTAN" within parentheses appears centered beneath "SAMSCA".
Trademark Events
Jan 8, 2020
Review Of Correspondence Complete - Address Updated
Dec 10, 2019
Correspondence Received In Law Office
Aug 26, 2016
Cancelled Sec. 8 (6-Yr)
Jan 19, 2010
Registered-Principal Register
Nov 3, 2009
Official Gazette Publication Confirmation E-Mailed
Nov 3, 2009
Published For Opposition
Sep 25, 2009
Law Office Publication Review Completed
Sep 25, 2009
Assigned To Lie
Sep 15, 2009
Approved For Pub - Principal Register
Sep 15, 2009
Use Amendment Accepted
Sep 15, 2009
Assigned To Examiner
Aug 7, 2009
Amendment To Use Processing Complete
Aug 7, 2009
Use Amendment Filed
Aug 6, 2009
Teas Amendment Of Use Received
Jun 20, 2009
Notice Of Design Search Code Mailed
Jun 19, 2009
New Application Office Supplied Data Entered In Tram